Bioimpedance Analyzers Market by Type (Single, Multi & Dual Frequency), Modality (Wired, Wireless), Application (Segmental Body Measurement, Whole Body Measurement), End User (Fitness Clubs, Home Users, Hospitals), & Region- Global Forecast to 2028
The global bioimpedance analyzers market is projected to reach USD 927 million by 2028 from USD 564 million in 2023, at a CAGR of 10.4% during the forecast period. The growth of this market is majorly driven by the promotion of healthy lifestyles by the government, growing fitness and wellness centers, and an increase in the number of nutritionists and dieticians. However, However, issues related high cost of professional-grade bioimpedance analyzers restrain the growth of the bioimpedance analyzers market.
“The multi-frequency bioimpedance analyzers segment accounted for the highest market share in the bioimpedance analyzers market, by product, during the forecast period.”
Based on the product segment, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with other technologies, such as wearable devices or imaging techniques for enhancing data analysis.
“Fitness clubs & wellness centers accounted for the highest CAGR during the forecast period.”
Based on end users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs & wellness centers, home users, and other end users. The fitness clubs & wellness centers segment dominated the bioimpedance analyzers market in 2022. This segment is expected to grow at the highest CAGR during the forecast period. The growing gyms and wellness centers and the rising awareness about health & fitness are the key factors driving market growth.
“The North America segment accounted for the highest market share in the bioimpedance analyzers market, by region, during the forecast period.”
Based on the region, the global bioimpedance analyzers market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced bioimpedance analyzers and the increasing adoption of healthy lifestyles are supporting the growth of the bioimpedance analyzers market.
Breakdown of supply-side primary interviews by company type, designation, and region:
Research Coverage
This research report categorizes the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioimpedance analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the bioimpedance analyzers market. Competitive analysis of upcoming startups in the bioimpedance analyzers market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioimpedance analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
“The multi-frequency bioimpedance analyzers segment accounted for the highest market share in the bioimpedance analyzers market, by product, during the forecast period.”
Based on the product segment, the bioimpedance analyzers market is classified into multi-frequency, single-frequency, and dual-frequency bioimpedance analyzers. In 2022, the multi-frequency bioimpedance analyzers segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to their integration with other technologies, such as wearable devices or imaging techniques for enhancing data analysis.
“Fitness clubs & wellness centers accounted for the highest CAGR during the forecast period.”
Based on end users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs & wellness centers, home users, and other end users. The fitness clubs & wellness centers segment dominated the bioimpedance analyzers market in 2022. This segment is expected to grow at the highest CAGR during the forecast period. The growing gyms and wellness centers and the rising awareness about health & fitness are the key factors driving market growth.
“The North America segment accounted for the highest market share in the bioimpedance analyzers market, by region, during the forecast period.”
Based on the region, the global bioimpedance analyzers market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced bioimpedance analyzers and the increasing adoption of healthy lifestyles are supporting the growth of the bioimpedance analyzers market.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
- By Designation: C-level (28%), Director-level (33%), and Others (39%)
- By Region: North America (21%), Asia- Pacific (34%), Europe (30%), and RoW (15%)
Research Coverage
This research report categorizes the bioimpedance analyzers market by product, modality, usage type, application, end-user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the bioimpedance analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the bioimpedance analyzers market. Competitive analysis of upcoming startups in the bioimpedance analyzers market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bioimpedance analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the bioimpedance analyzers market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioimpedance analyzers market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the bioimpedance analyzers market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the bioimpedance analyzers market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like OMRON Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), Seca GmbH & Co. KG (Germany), among others in the bioimpedance analyzers market strategies.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
TABLE 2 KEY DATA FROM PRIMARY SOURCES
2.1.2.1 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.1 Growth forecast
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2023 VS. 2028 (USD BILLION)
FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION)
FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION)
FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
FIGURE 14 BIOIMPEDANCE ANALYZERS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
FIGURE 15 INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS MARKET
4.2 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 2022
4.3 REGIONAL GROWTH OPPORTUNITIES IN BIOIMPEDANCE ANALYZERS MARKET
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 BIOIMPEDANCE ANALYZERS MARKET: REGIONAL MIX
FIGURE 18 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 BIOIMPEDANCE ANALYZERS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 BIOIMPEDANCE ANALYZERS MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of lifestyle diseases
5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
5.2.2 RESTRAINTS
5.2.2.1 Presence of alternative methods
5.2.2.2 High cost of analyzers
TABLE 3 BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets across Asia Pacific and Latin America
5.2.3.2 Integration with wearable devices
5.2.4 CHALLENGES
5.2.4.1 Inconsistency in accuracy of different bioimpedance analyzers
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 22 BIOIMPEDANCE ANALYZERS MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 23 BIOIMPEDANCE ANALYZERS MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 24 BIOIMPEDANCE ANALYZERS MARKET ECOSYSTEM: KEY PLAYERS
5.6 REGULATORY LANDSCAPE
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
5.6.1.2 Canada
TABLE 5 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.2 EUROPE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
TABLE 8 REGULATORY AUTHORITIES
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS
FIGURE 25 PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013–NOVEMBER 2022)
5.9 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 10 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
5.10 TECHNOLOGY ANALYSIS
5.11 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
FIGURE 26 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS
6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 12 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
6.2.1 ACCURACY AND PRECISION TO DRIVE MARKET
TABLE 13 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 14 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE MARKET
TABLE 15 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 16 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
6.4.1 SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH
TABLE 17 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 18 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY
7.1 INTRODUCTION
TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
7.2 WIRELESS BIOIMPEDANCE ANALYZERS
7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE
TABLE 20 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 WIRED BIOIMPEDANCE ANALYZERS
7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE DEMAND
TABLE 21 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE
8.1 INTRODUCTION
TABLE 22 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
8.2 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS
8.2.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET
TABLE 23 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS
8.3.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET
TABLE 24 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 SEGMENTAL BODY MEASUREMENT
9.2.1 RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION
TABLE 26 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
9.3 WHOLE-BODY MEASUREMENT
9.3.1 GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET
TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 28 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 FITNESS CLUBS & WELLNESS CENTERS
10.2.1 FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET
FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012–2022
TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021–2028 (USD MILLION)
10.3 HOME USERS
10.3.1 AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION
TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2021–2028 (USD MILLION)
10.4 HOSPITALS & CLINICS
10.4.1 NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION
TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
10.5 OTHER END USERS
TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 33 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 RECESSION IMPACT
11.2.2 US
11.2.2.1 Rising obesity rate and interest in health clubs & fitness centers to drive market
TABLE 40 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 41 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 42 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 43 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 High prevalence of obesity in Canada to support market growth
TABLE 44 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 45 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 46 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 47 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 EUROPE
TABLE 48 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.1 RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Germany to hold largest market share in Europe
TABLE 54 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 56 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising incidence of kidney disorders to drive market
TABLE 58 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 59 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 60 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 61 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Increasing obese population and rising prevalence of metabolic disorders to drive market
TABLE 62 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 64 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.5 REST OF EUROPE
TABLE 66 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 68 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 69 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 RECESSION IMPACT
FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
TABLE 70 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Government initiatives to drive market
TABLE 76 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 78 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 China to register highest CAGR in APAC market
TABLE 80 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 82 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 83 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 High prevalence of obesity to drive market
TABLE 84 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 85 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 86 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.5 PHILIPPINES
11.4.5.1 Favorable government initiatives to support market growth
TABLE 88 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 90 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.6 TAIWAN
11.4.6.1 Increasing incidence of lifestyle diseases to drive market
TABLE 92 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 93 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 94 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 96 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 99 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 REST OF THE WORLD
11.5.1 RECESSION IMPACT
TABLE 100 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 101 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 102 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 103 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
12.3 MARKET SHARE ANALYSIS
TABLE 105 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
12.4 COMPANY EVALUATION MATRIX (2022)
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
FIGURE 30 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022
12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
FIGURE 31 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
12.6 COMPETITIVE BENCHMARKING
TABLE 106 BIOIMPEDANCE ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 107 PRODUCT FOOTPRINT ANALYSIS
TABLE 108 REGIONAL FOOTPRINT ANALYSIS
TABLE 109 BIOIMPEDANCE ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES
TABLE 110 PRODUCT LAUNCHES, 2020–2023
12.7.2 DEALS
TABLE 111 DEALS, 2020–2023
12.7.3 OTHER DEVELOPMENTS
TABLE 112 OTHER DEVELOPMENTS, 2020–2023
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 OMRON CORPORATION
TABLE 113 OMRON CORPORATION: BUSINESS OVERVIEW
FIGURE 32 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
13.1.2 TANITA CORPORATION
TABLE 114 TANITA CORPORATION: BUSINESS OVERVIEW
13.1.3 INBODY CO., LTD.
TABLE 115 INBODY CO., LTD.: BUSINESS OVERVIEW
TABLE 116 INBODY CO., LTD.: DEALS
TABLE 117 INBODY CO., LTD.: OTHER DEVELOPMENTS
13.1.4 RJL SYSTEMS, INC.
TABLE 118 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
13.1.5 SECA GMBH & CO. KG
TABLE 119 SECA GMBH & CO. KG: BUSINESS OVERVIEW
13.1.6 EVOLT 360
TABLE 120 EVOLT 360: BUSINESS OVERVIEW
13.1.7 SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL)
TABLE 121 SELVAS HEALTHCARE: BUSINESS OVERVIEW
13.1.8 FOOK TIN TECHNOLOGIES LTD.
TABLE 122 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
13.1.9 BODYSTAT LTD.
TABLE 123 BODYSTAT LTD.: BUSINESS OVERVIEW
TABLE 124 BODYSTAT LTD.: PRODUCT LAUNCHES
13.1.10 CHARDER ELECTRONIC CO., LTD.
TABLE 125 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
13.1.11 MALTRON INTERNATIONAL
TABLE 126 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 BIOTEKNA
13.2.2 BIODYNAMICS CORPORATION
13.2.3 AKERN
13.2.4 WITHINGS
13.2.5 XIAOMI
13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
13.2.7 LUMSAIL INDUSTRIAL INC.
13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
13.2.9 BIOPARHOM
13.2.10 MICROLIFE
13.2.11 SONKA MEDICAL TECHNOLOGY CO., LIMITED
13.2.12 NUMED S.A.R.L.
13.2.13 WUNDER SA.BI. SRL.
13.2.14 SHENZHEN YOLANDA TECHNOLOGY CO., LTD
13.2.15 BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 BIOIMPEDANCE ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
TABLE 2 KEY DATA FROM PRIMARY SOURCES
2.1.2.1 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.1 Growth forecast
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2023 VS. 2028 (USD BILLION)
FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2023 VS. 2028 (USD BILLION)
FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD BILLION)
FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
FIGURE 14 BIOIMPEDANCE ANALYZERS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
FIGURE 15 INCREASED PREVALENCE OF OBESITY TO DRIVE BIOIMPEDANCE ANALYZERS MARKET
4.2 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS ACCOUNTED FOR LARGEST SHARE IN 2022
4.3 REGIONAL GROWTH OPPORTUNITIES IN BIOIMPEDANCE ANALYZERS MARKET
FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 BIOIMPEDANCE ANALYZERS MARKET: REGIONAL MIX
FIGURE 18 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 BIOIMPEDANCE ANALYZERS MARKET: DEVELOPED VS. EMERGING ECONOMIES
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 BIOIMPEDANCE ANALYZERS MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of lifestyle diseases
5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
5.2.2 RESTRAINTS
5.2.2.1 Presence of alternative methods
5.2.2.2 High cost of analyzers
TABLE 3 BIOIMPEDANCE ANALYZERS: AVERAGE PRICE RANGE, BY COMPANY
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets across Asia Pacific and Latin America
5.2.3.2 Integration with wearable devices
5.2.4 CHALLENGES
5.2.4.1 Inconsistency in accuracy of different bioimpedance analyzers
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 21 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 22 BIOIMPEDANCE ANALYZERS MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 23 BIOIMPEDANCE ANALYZERS MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 24 BIOIMPEDANCE ANALYZERS MARKET ECOSYSTEM: KEY PLAYERS
5.6 REGULATORY LANDSCAPE
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
5.6.1.2 Canada
TABLE 5 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.6.2 EUROPE
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6.3.2 China
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India
TABLE 8 REGULATORY AUTHORITIES
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS
FIGURE 25 PATENT ANALYSIS FOR BIOIMPEDANCE ANALYZERS (JANUARY 2013–NOVEMBER 2022)
5.9 TRADE ANALYSIS
TABLE 9 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 10 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES (NES), BY COUNTRY, 2018–2022 (USD MILLION)
5.10 TECHNOLOGY ANALYSIS
5.11 PRICING ANALYSIS
TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
FIGURE 26 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS
6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 12 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
6.2.1 ACCURACY AND PRECISION TO DRIVE MARKET
TABLE 13 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 14 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE MARKET
TABLE 15 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 16 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
6.4.1 SUITABILITY FOR ADVANCED CLINICAL AND RESEARCH APPLICATIONS TO FAVOR GROWTH
TABLE 17 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS OFFERED, BY COMPANY
TABLE 18 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY
7.1 INTRODUCTION
TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
7.2 WIRELESS BIOIMPEDANCE ANALYZERS
7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS TO HOLD LARGEST MARKET SHARE
TABLE 20 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 WIRED BIOIMPEDANCE ANALYZERS
7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE DEMAND
TABLE 21 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
8 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE
8.1 INTRODUCTION
TABLE 22 BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
8.2 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS
8.2.1 GROWING NUMBER OF FITNESS & WELLNESS CENTERS TO DRIVE MARKET
TABLE 23 PROFESSIONAL-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS
8.3.1 GROWING AWARENESS OF FITNESS AND TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE MARKET
TABLE 24 CONSUMER-GRADE BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 SEGMENTAL BODY MEASUREMENT
9.2.1 RISING EMPHASIS ON MONITORING TRAINING EFFECTIVENESS TO BOOST ADOPTION
TABLE 26 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
9.3 WHOLE-BODY MEASUREMENT
9.3.1 GROWING USE OF WHOLE-BODY ANALYZERS TO DRIVE MARKET
TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2021–2028 (USD MILLION)
10 BIOIMPEDANCE ANALYZERS MARKET, BY END USER
10.1 INTRODUCTION
TABLE 28 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 FITNESS CLUBS & WELLNESS CENTERS
10.2.1 FITNESS CLUBS & WELLNESS CENTERS TO DOMINATE END-USER MARKET
FIGURE 27 US: NUMBER OF HEALTH CLUBS, 2012–2022
TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS & WELLNESS CENTERS, 2021–2028 (USD MILLION)
10.3 HOME USERS
10.3.1 AFFORDABILITY AND CONVENIENCE TO DRIVE ANALYZER ADOPTION
TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2021–2028 (USD MILLION)
10.4 HOSPITALS & CLINICS
10.4.1 NEED TO MONITOR NUTRITIONAL, HYDRATION STATES AND OTHER PARAMETERS TO BOOST ADOPTION
TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
10.5 OTHER END USERS
TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
11 BIOIMPEDANCE ANALYZERS MARKET, BY REGION
11.1 INTRODUCTION
TABLE 33 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
TABLE 34 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 36 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.1 RECESSION IMPACT
11.2.2 US
11.2.2.1 Rising obesity rate and interest in health clubs & fitness centers to drive market
TABLE 40 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 41 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 42 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 43 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 High prevalence of obesity in Canada to support market growth
TABLE 44 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 45 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 46 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 47 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3 EUROPE
TABLE 48 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 49 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 51 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 52 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 53 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.1 RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Germany to hold largest market share in Europe
TABLE 54 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 55 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 56 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising incidence of kidney disorders to drive market
TABLE 58 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 59 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 60 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 61 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Increasing obese population and rising prevalence of metabolic disorders to drive market
TABLE 62 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 64 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 65 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.5 REST OF EUROPE
TABLE 66 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 67 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 68 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 69 REST OF EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 RECESSION IMPACT
FIGURE 29 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
TABLE 70 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 73 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY USAGE TYPE, 2021–2028 (USD MILLION)
TABLE 74 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 75 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Government initiatives to drive market
TABLE 76 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 78 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 79 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 China to register highest CAGR in APAC market
TABLE 80 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 82 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 83 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 High prevalence of obesity to drive market
TABLE 84 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 85 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 86 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 87 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.5 PHILIPPINES
11.4.5.1 Favorable government initiatives to support market growth
TABLE 88 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 90 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 91 PHILIPPINES: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.6 TAIWAN
11.4.6.1 Increasing incidence of lifestyle diseases to drive market
TABLE 92 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 93 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 94 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 95 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 96 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 97 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 99 REST OF ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5 REST OF THE WORLD
11.5.1 RECESSION IMPACT
TABLE 100 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 101 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 102 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 103 REST OF THE WORLD: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 104 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
12.3 MARKET SHARE ANALYSIS
TABLE 105 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
12.4 COMPANY EVALUATION MATRIX (2022)
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
FIGURE 30 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022
12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
FIGURE 31 BIOIMPEDANCE ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
12.6 COMPETITIVE BENCHMARKING
TABLE 106 BIOIMPEDANCE ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 107 PRODUCT FOOTPRINT ANALYSIS
TABLE 108 REGIONAL FOOTPRINT ANALYSIS
TABLE 109 BIOIMPEDANCE ANALYZERS MARKET: DETAILED LIST OF KEY START-UPS/SMES
12.7 COMPETITIVE SCENARIO
12.7.1 PRODUCT LAUNCHES
TABLE 110 PRODUCT LAUNCHES, 2020–2023
12.7.2 DEALS
TABLE 111 DEALS, 2020–2023
12.7.3 OTHER DEVELOPMENTS
TABLE 112 OTHER DEVELOPMENTS, 2020–2023
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 OMRON CORPORATION
TABLE 113 OMRON CORPORATION: BUSINESS OVERVIEW
FIGURE 32 OMRON CORPORATION: COMPANY SNAPSHOT (2022)
13.1.2 TANITA CORPORATION
TABLE 114 TANITA CORPORATION: BUSINESS OVERVIEW
13.1.3 INBODY CO., LTD.
TABLE 115 INBODY CO., LTD.: BUSINESS OVERVIEW
TABLE 116 INBODY CO., LTD.: DEALS
TABLE 117 INBODY CO., LTD.: OTHER DEVELOPMENTS
13.1.4 RJL SYSTEMS, INC.
TABLE 118 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
13.1.5 SECA GMBH & CO. KG
TABLE 119 SECA GMBH & CO. KG: BUSINESS OVERVIEW
13.1.6 EVOLT 360
TABLE 120 EVOLT 360: BUSINESS OVERVIEW
13.1.7 SELVAS HEALTHCARE (FORMERLY JAWON MEDICAL)
TABLE 121 SELVAS HEALTHCARE: BUSINESS OVERVIEW
13.1.8 FOOK TIN TECHNOLOGIES LTD.
TABLE 122 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
13.1.9 BODYSTAT LTD.
TABLE 123 BODYSTAT LTD.: BUSINESS OVERVIEW
TABLE 124 BODYSTAT LTD.: PRODUCT LAUNCHES
13.1.10 CHARDER ELECTRONIC CO., LTD.
TABLE 125 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
13.1.11 MALTRON INTERNATIONAL
TABLE 126 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 BIOTEKNA
13.2.2 BIODYNAMICS CORPORATION
13.2.3 AKERN
13.2.4 WITHINGS
13.2.5 XIAOMI
13.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
13.2.7 LUMSAIL INDUSTRIAL INC.
13.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
13.2.9 BIOPARHOM
13.2.10 MICROLIFE
13.2.11 SONKA MEDICAL TECHNOLOGY CO., LIMITED
13.2.12 NUMED S.A.R.L.
13.2.13 WUNDER SA.BI. SRL.
13.2.14 SHENZHEN YOLANDA TECHNOLOGY CO., LTD
13.2.15 BODIVIS (TONGFANG HEALTH TECHNOLOGY CO., LTD.)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
